Vascular Dementia

Vascular Dementia refers to the decline in thinking ability caused by cerebrovascular diseases. Discover the latest research on aspects underlying vascular dementia here.

September 19, 2020
Open Access

Pinocembrin Ameliorates Cognitive Impairment Induced by Vascular Dementia: Contribution of Reelin-dab1 Signaling Pathway

Drug Design, Development and Therapy
Ze-Chun KangGuan-Hua Du
September 26, 2020

Diagnosis and treatment of vascular dementia

Zeitschrift für Gerontologie und Geriatrie
Markus A HobertWalter Maetzler
September 22, 2020
Open Access

IgA natural antibodies are produced following T-cell independent B-cell activation following stroke

Brain, Behavior, and Immunity
Jacob C ZbeskoKristian P Doyle
September 20, 2020
Review

Potential human transmission of amyloid β pathology: surveillance and risks

Lancet Neurology
Elsa LauwersBart De Strooper
September 11, 2020

Prevalence of ocular abnormalities in relation to sickle cell disease severity among children in South-western, Nigeria

European Journal of Ophthalmology
Oluwatoyin I OladimejiSamuel A Adegoke
September 6, 2020

Association between concurrent antidepressant and hypnotic treatment and the risk of dementia: A nationwide cohort study

Journal of Affective Disorders
Ching-En LinWu-Chien Chien
September 3, 2020
Preprint
Open Access

Single-vessel cerebral blood flow fMRI to map blood velocity by phase-contrast imaging

BioRxiv : the Preprint Server for Biology
X. ChenXin Yu
September 10, 2020
Review
Open Access

An Iatrogenic Model of Brain Small-Vessel Disease: Post-Radiation Encephalopathy

International Journal of Molecular Sciences
Rita Moretti, Paola Caruso
September 15, 2020

Vascular Risk Factors of Hippocampal Subfield Volumes in Persons without Dementia: The Medea 7T Study

Journal of Alzheimer's Disease : JAD
Kim BlomUCC-SMART Study Group
September 16, 2020

Age-related changes in the immune system and cognitive disorders in vascular dementia and Alzheimer's disease

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
M B Nuvakhova, S A Rachin
September 10, 2020
Review
Open Access

Biomarkers for Alzheimer's Disease Early Diagnosis

Journal of Personalized Medicine
Eva AusóGema Esquiva
September 26, 2020
Open Access

Neuropsychiatric symptoms in brain diseases - historical foundations

Dementia & Neuropsychologia
Eliasz EngelhardtJerson Laks
September 7, 2020
Preprint
Open Access

Homocysteine in Neurology: A Risk Factor or Something Different in Small Vessel Disease

Preprints.org
Rita MorettiClaudio Tiribelli
September 15, 2020
Open Access

The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer's disease

Acta Neuropathologica
Baayla D C BoonJeroen J M Hoozemans
September 18, 2020
Preprint
Open Access

Risk Factors for Progression to Alzheimer's Disease in African Americans in a Large National Cohort

MedRxiv : the Preprint Server for Health Sciences
Yejin KimX. Jiang
September 13, 2020
Open Access

Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease

Scientific Reports
Giovanni ZulianiCarlo Cervellati

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

© 2020 Meta ULC. All rights reserved
/feed-previews/vascular-dementia/61137a20-82ff-4ffe-b807-bc3f4e595435